RenovoRx (RNXT) Stock Chart & Stock Price History $1.12 +0.01 (+0.45%) As of 01:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RenovoRx Stock Price Performance The RenovoRx (RNXT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 1.75%, with a year-to-date return of -13.18%. In the past month, the stock has decreased 12.84%, reflecting recent market activity. As of the latest close, RenovoRx traded at $1.12 with a market cap of $40.78 million and volume of 174,699 shares. Receive RNXT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RenovoRx and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.67%1 Month Performance-12.84%3 Month Performance+5.66%Year-To-Date Performance-13.18%1 Year Performance-1.75% RNXT Stock Chart for Tuesday, August, 12, 2025 RNXT Chart by TradingView RenovoRx Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/11/2025$1.14$1.12-2.19%$1.15$1.11174,699 shs$40.78 million08/08/2025$1.20$1.14-5.00%$1.22$1.11194,041 shs$41.69 million08/07/2025$1.20$1.20$1.24$1.1740,703 shs$43.88 million08/06/2025$1.22$1.20-1.64%$1.24$1.2084,421 shs$43.88 million08/05/2025$1.21$1.22+0.83%$1.24$1.2042,267 shs$44.62 million08/04/2025$1.21$1.21$1.28$1.2173,217 shs$44.25 million08/01/2025$1.24$1.21-2.42%$1.24$1.2165,992 shs$44.25 million07/31/2025$1.20$1.24+3.33%$1.27$1.20137,648 shs$45.35 million07/30/2025$1.22$1.20-1.64%$1.25$1.2061,771 shs$43.88 million07/29/2025$1.25$1.22-2.40%$1.28$1.22140,415 shs$44.62 million Get the Latest News and Ratings for RNXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RenovoRx and its competitors with MarketBeat's FREE daily newsletter. 07/28/2025$1.27$1.25-1.57%$1.31$1.2466,112 shs$45.71 million07/25/2025$1.30$1.27-2.31%$1.30$1.2751,295 shs$46.44 million07/24/2025$1.27$1.30+2.36%$1.30$1.26113,714 shs$47.54 million07/23/2025$1.28$1.27-0.78%$1.28$1.2427,262 shs$46.45 million07/22/2025$1.29$1.28-0.78%$1.30$1.23110,602 shs$46.81 million07/21/2025$1.30$1.29-0.77%$1.31$1.26119,957 shs$47.18 million07/18/2025$1.30$1.30$1.35$1.28128,984 shs$47.54 million07/17/2025$1.30$1.30$1.32$1.28125,806 shs$47.54 million07/16/2025$1.32$1.30-1.52%$1.33$1.27100,785 shs$47.54 million07/15/2025$1.40$1.32-5.71%$1.39$1.30242,438 shs$48.28 million07/14/2025$1.29$1.40+8.95%$1.40$1.29214,312 shs$51.20 million07/11/2025$1.34$1.29-4.10%$1.37$1.28150,962 shs$47.00 million Related Companies LYEL Stock Price Chart CYBN Stock Price Chart TIL Stock Price Chart RAPT Stock Price Chart CRDF Stock Price Chart LFVN Stock Price Chart ACRS Stock Price Chart DERM Stock Price Chart PBYI Stock Price Chart BIOA Stock Price Chart Receive RNXT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RenovoRx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNXT) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovoRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RenovoRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access